ClinicalTrials.gov
public full text
Public Domain
Escitalopram (Lexapro) for the Treatment of Postpartum Depression
The purpose of this study is to determine whether women with postpartum major depressive disorder (MDD) will experience a significant decrease in depressive symptoms from baseline over an eight-week treatment intervention with escitalopram (Lexapro). Also, to determine whether women with postpartum MDD will experience a significant decrease in anxiety symptoms.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Trial Examining the Efficacy of Escitalopram Oxalate Upon Depressive Symptoms and Fatigue in HIV Seropositive Women#911346
- Postpartum Depression in the United States: A Systematic Review of Epidemiology, Risk Factors, and Contemporary Management With Emphasis on Emerging Therapeutic and Digital Care Models.#330661
- Psychiatric History and Postpartum Depression: The Mediating Role of Obstetric Complications.#425144
- Postpartum Depression and Cesarean Section#857020
- Implementation of a clinical decision support tool for postpartum depression: protocol for a prospective randomised clinical trial.#209424
Record · ID 843645
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive